GeneDx Integrates with Epic to Expand Genome and Exome Sequencing for Faster Diagnosis and Treatment
GeneDx (Nasdaq: WGS), a leader in genomic insights for improved health outcomes, announced the launch of its integration with Aura, Epic’s specialty diagnostics suite. This integration allows health systems to order and receive results for advanced genetic sequencing directly within electronic health records (EHR). By offering seamless access to its leading diagnostic tests, including exome sequencing (ES), whole genome sequencing (WGS), and rapid whole genome sequencing (rWGS), GeneDx aims to provide fast, accurate genetic diagnoses and accelerate patient treatment. UNC Health is the first health system to integrate with GeneDx through Aura, with additional health systems now able to connect and leverage these advanced genetic tests.
GeneDx, a leader in genomic testing, recently announced the integration of its advanced genetic testing services with Epic’s Aura, a specialty diagnostics suite. This integration provides health systems with direct access to GeneDx’s powerful genomic tests through their existing electronic health record (EHR) systems. It enables healthcare providers to order and receive results for genetic tests, including exome sequencing (ES), whole genome sequencing (WGS), and rapid whole genome sequencing (rWGS), all within their familiar EHR environment.
This new integration is designed to streamline the diagnostic process for healthcare providers, making genetic testing more accessible, efficient, and accurate. With the integration of Aura, genetic test results are automatically incorporated into the patient’s EHR alongside other lab results, eliminating the need for clinicians to search through separate sections or systems. Michael Adams, MD, Pediatric Genetics and Metabolism at UNC Health, emphasized the significant benefits of this integration, noting that it not only simplifies the implementation process but also enhances the visibility and accessibility of genetic results. The structured data format provided by Aura also paves the way for future research opportunities and quality improvements within health systems.
GeneDx’s integration with Epic Aura empowers clinicians to deliver faster and more accurate genetic diagnoses, allowing for timely, targeted treatments that improve patient outcomes. Genetic testing has become an essential tool in diagnosing a wide range of conditions, especially rare and inherited diseases, where traditional diagnostic methods often fall short. With this new integration, health systems can now access GeneDx’s diagnostic capabilities directly from their EHR, ensuring that genetic tests are seamlessly incorporated into the patient care process.
Katherine Stueland, President and CEO of GeneDx, highlighted the company’s commitment to providing patient-centered solutions through this integration. By simplifying the process of obtaining genetic test results, GeneDx ensures that clinicians can quickly access the information they need to make informed decisions about patient care. Stueland emphasized that the company’s track record speaks for itself, with 8 out of 10 genetics experts relying on GeneDx for exome and genome testing. GeneDx’s ability to empower clinicians with accurate genomic insights has been instrumental in changing clinical care practices and improving health outcomes for patients.
As more health systems integrate with GeneDx through Epic Aura, the adoption of exome and genome sequencing is expected to grow, helping to incorporate genetic insights into routine clinical care across various medical specialties. These specialties include pediatrics, neonatology, pediatric neurology, and medical genetics, among others. By providing healthcare providers with easy access to genetic testing within their EHR, GeneDx is helping to make precision medicine a more routine part of clinical practice.
GeneDx is recognized for its unparalleled expertise in genomic sequencing, having sequenced over 750,000 exomes and genomes. This vast experience, combined with the millions of phenotypic data points gathered over the years, has allowed the company to build one of the largest rare disease data sets in the world. This extensive database plays a crucial role in improving diagnostic accuracy and helping clinicians make better-informed decisions for their patients. GeneDx’s efforts are also contributing to advancing drug discovery and improving overall health system efficiencies.
The integration of GeneDx with Epic Aura is expected to drive significant improvements in the use of genetic testing in clinical care. By making genomic insights more accessible and integrated within existing health system workflows, GeneDx is ensuring that patients receive faster, more accurate diagnoses and targeted treatments.
About GeneDx
GeneDx (Nasdaq: WGS) is a leading provider of genomic diagnostic testing with a mission to offer personalized, targeted medical care that starts with a genetic diagnosis. With one of the world’s largest rare disease data sets, GeneDx uses its industry-leading exome and genome tests to translate complex genomic data into actionable clinical insights. These insights help to unlock personalized health plans, accelerate drug discovery, and improve the efficiency of health systems.
